Display options
Cite
Sharma HS, Das DK. Role of cytokines in myocardial ischemia and reperfusion. Mediators Inflamm. 1997;6(3):175-83doi: 10.1080/09629359791668.
Sharma, H. S., & Das, D. K. (1997). Role of cytokines in myocardial ischemia and reperfusion. Mediators of inflammation, 6(3), 175-83. https://doi.org/10.1080/09629359791668
Sharma, H S, and Das, D K. "Role of cytokines in myocardial ischemia and reperfusion." Mediators of inflammation vol. 6,3 (1997): 175-83. doi: https://doi.org/10.1080/09629359791668
Sharma HS, Das DK. Role of cytokines in myocardial ischemia and reperfusion. Mediators Inflamm. 1997;6(3):175-83. doi: 10.1080/09629359791668. PMID: 18472818; PMCID: PMC2365828.
Copy Download .nbib Format: NLM
Share it on

Mediators Inflamm. 1997;6(3):175-83. doi: 10.1080/09629359791668.

Role of cytokines in myocardial ischemia and reperfusion.

Mediators of inflammation

H S Sharma, D K Das

Affiliations

  1. Department of Pharmacology Erasmus University Rotterdam The Netherlands.

PMID: 18472818 PMCID: PMC2365828 DOI: 10.1080/09629359791668

Abstract

Mediators of myocardial inflammation, predominantly cytokines, have for many years been implicated in the healing processes after infarction. In recent years, however, more attention has been paid to the possibility that the inflammation may result in deleterious complications for myocardial infarction. The proinflammatory cytokines may mediate myocardial dysfunction associated with myocardial infarction, severe congestive heart failure, and sepsis. A growing body of literature suggests that inflammatory mediators could play a crucial role in ischemia-reperfusion injury. Furthermore, ischemia-reperfusion not only results in the local transcriptional and translational upregulation of cytokines but also leads to tissue infiltration by inflammatory cells. These inflammatory cells are a ready source of a variety of cytokines which could be lethal for the cardiomyocytes. At the cellular level it has been shown that hypoxia causes a series of well documented changes in cardiomyocytes that includes loss of contractility, changes in lipid metabolism and subsequent irreversible cell membrane damage leading to cell death. For instance, hypoxic cardiomyocytes produce interleukin-6 (IL-6) which could contribute to the myocardial dysfunction observed in ischemia reperfusion injury. Ischemia followed by reperfusion induces a number of other multi-potent cytokines, such as IL-1, IL-8, tumor necrosis factor-alpha (TNF-alpha), transforming growth factor-beta1 (TGF-beta1) as well as an angiogenic cytokine/ growth factor, vascular endothelial growth factor (VEGF), in the heart. Intrestingly, these multipotent cytokines (e.g. TNF-alpha) may induce an adaptive cytoprotective response in the reperfused myocardium. In this review, we have included a number of cytokines that may contribute to ventricular dysfunction and/or to the cytoprotective and adaptive changes in the reperfused heart.

References

  1. Cardiology. 1990;77(5):367-72 - PubMed
  2. Physiol Rev. 1992 Oct;72(4):1063-81 - PubMed
  3. Annu Rev Physiol. 1992;54:243-56 - PubMed
  4. Cardiovasc Res. 1993 Aug;27(8):1421-9 - PubMed
  5. Arch Pathol. 1960 Jul;70:68-78 - PubMed
  6. Eur J Immunol. 1988 May;18(5):717-21 - PubMed
  7. Immunol Lett. 1988 Nov;19(3):183-91 - PubMed
  8. Mol Cell Biochem. 1996 Apr 12-26;157(1-2):111-6 - PubMed
  9. Eur J Pharmacol. 1991 Jan 25;206(1):53-60 - PubMed
  10. J Cell Biol. 1988 Oct;107(4):1269-77 - PubMed
  11. J Clin Invest. 1991 Jan;87(1):139-47 - PubMed
  12. J Cell Biochem. 1995 Jun;58(2):248-59 - PubMed
  13. Annu Rev Med. 1994;45:491-503 - PubMed
  14. Proc Natl Acad Sci U S A. 1991 Oct 15;88(20):9292-6 - PubMed
  15. Ann N Y Acad Sci. 1996 Sep 30;793:267-81 - PubMed
  16. J Clin Invest. 1993 Nov;92(5):2303-12 - PubMed
  17. Am J Cardiol. 1993 May 15;71(13):1231-2 - PubMed
  18. Circ Res. 1992 Dec;71(6):1351-60 - PubMed
  19. Basic Res Cardiol. 1989 Sep-Oct;84(5):524-35 - PubMed
  20. Circulation. 1990 Sep;82(3):723-38 - PubMed
  21. Basic Res Cardiol. 1992 Jan-Feb;87(1):12-8 - PubMed
  22. Biotherapy. 1989;1(4):327-38 - PubMed
  23. Ann N Y Acad Sci. 1994 Jun 17;723:491-4 - PubMed
  24. Circ Res. 1985 Feb;56(2):262-78 - PubMed
  25. Cancer Res. 1990 Nov 15;50(22):7101-7 - PubMed
  26. J Cardiovasc Pharmacol. 1992;20 Suppl 1:S23-31 - PubMed
  27. Cardiovasc Res. 1993 Nov;27(11):2037-43 - PubMed
  28. Am J Physiol. 1994 Nov;267(5 Pt 2):H1753-8 - PubMed
  29. J Mol Cell Cardiol. 1995 Jan;27(1):121-31 - PubMed
  30. Annu Rev Pharmacol Toxicol. 1986;26:201-24 - PubMed
  31. Cardiovasc Res. 1988 Jan;22(1):37-41 - PubMed
  32. EMBO J. 1990 May;9(5):1503-10 - PubMed
  33. Arch Surg. 1992 Feb;127(2):138-44; discussion 144-5 - PubMed
  34. FEBS Lett. 1989 Dec 4;258(2):269-73 - PubMed
  35. Circ Res. 1990 Apr;66(4):1133-42 - PubMed
  36. J Thorac Cardiovasc Surg. 1995 Oct;110(4 Pt 1):1047-53 - PubMed
  37. FASEB J. 1988 Aug;2(11):2702-6 - PubMed
  38. Circ Res. 1990 Apr;66(4):913-31 - PubMed
  39. Basic Res Cardiol. 1986 Mar-Apr;81(2):155-66 - PubMed
  40. Science. 1990 Jul 6;249(4964):61-4 - PubMed
  41. J Biol Chem. 1992 Jun 5;267(16):10931-4 - PubMed
  42. Biochem Biophys Res Commun. 1991 Dec 16;181(2):520-3 - PubMed
  43. N Engl J Med. 1981 Feb 26;304(9):497-503 - PubMed
  44. J Cardiovasc Pharmacol. 1991;17 Suppl 2:S117-8 - PubMed
  45. J Thorac Cardiovasc Surg. 1989 Dec;98(6):1100-6 - PubMed
  46. Circulation. 1994 Aug;90(2):694-9 - PubMed
  47. Biochem Biophys Res Commun. 1992 Apr 30;184(2):1056-9 - PubMed
  48. Am J Pathol. 1995 Feb;146(2):419-28 - PubMed
  49. FASEB J. 1990 Aug;4(11):2860-7 - PubMed
  50. Immunol Res. 1992;11(2):81-90 - PubMed
  51. Cardiovasc Res. 1993 Aug;27(8):1486-90 - PubMed
  52. J Mol Cell Cardiol. 1992 Feb;24(2):113-24 - PubMed
  53. J Thorac Cardiovasc Surg. 1987 Jun;93(6):860-6 - PubMed
  54. Science. 1987 Sep 11;237(4820):1333-6 - PubMed
  55. J Mol Cell Cardiol. 1986 Sep;18(9):953-61 - PubMed
  56. J Thorac Cardiovasc Surg. 1994 Oct;108(4):626-35 - PubMed
  57. Scand J Thorac Cardiovasc Surg. 1988;22(1):51-3 - PubMed
  58. Br J Pharmacol. 1992 Mar;105(3):575-80 - PubMed
  59. Bioessays. 1990 Jan;12(1):22-6 - PubMed
  60. Int J Immunopharmacol. 1993 Jul;15(5):581-7 - PubMed
  61. FASEB J. 1988 Feb;2(2):108-15 - PubMed
  62. J Mol Cell Cardiol. 1992 Jun;24(6):579-84 - PubMed
  63. J Clin Invest. 1988 Apr;81(4):1162-72 - PubMed
  64. Circulation. 1995 Mar 1;91(5):1520-4 - PubMed
  65. J Mol Cell Cardiol. 1995 Aug;27(8):1669-78 - PubMed
  66. Proc Natl Acad Sci U S A. 1986 Jun;83(12):4167-71 - PubMed
  67. J Clin Invest. 1991 Apr;87(4):1312-21 - PubMed
  68. Circ Res. 1993 Nov;73(5):783-91 - PubMed
  69. Circulation. 1994 Jul;90(1):375-83 - PubMed
  70. Neuroreport. 1992 Jun;3(6):519-20 - PubMed
  71. Cell Tissue Res. 1989 Jun;256(3):553-8 - PubMed
  72. J Biol Chem. 1994 Nov 4;269(44):27580-8 - PubMed
  73. J Mol Cell Cardiol. 1991 Sep;23(9):1051-62 - PubMed
  74. Biochem Pharmacol. 1991 Sep 12;42(7):1323-7 - PubMed
  75. Trends Cell Biol. 1992 Apr;2(4):98-103 - PubMed
  76. J Natl Cancer Inst. 1993 Oct 6;85(19):1558-70 - PubMed
  77. J Mol Cell Cardiol. 1996 Jun;28(6):1261-70 - PubMed
  78. Circulation. 1996 Feb 15;93(4):704-11 - PubMed
  79. J Mol Cell Cardiol. 1995 Jan;27(1):45-52 - PubMed
  80. Annu Rev Biochem. 1992;61:761-807 - PubMed
  81. Mol Cell Biochem. 1995 Mar 9;144(1):67-74 - PubMed
  82. Mol Cell Biochem. 1996 Jul-Aug;160-161:217-24 - PubMed
  83. J Mol Cell Cardiol. 1995 Oct;27(10):2091-9 - PubMed
  84. J Immunol. 1986 Jun 15;136(12):4509-14 - PubMed
  85. Eur Heart J. 1990 Sep;11(9):800-13 - PubMed
  86. Annu Rev Biochem. 1989;58:799-839 - PubMed
  87. J Biol Chem. 1992 Sep 5;267(25):17997-8001 - PubMed
  88. Cardiovasc Drugs Ther. 1994 Jun;8(3):461-8 - PubMed
  89. Ann N Y Acad Sci. 1994 Jun 17;723:258-70 - PubMed
  90. Clin Chem. 1990 Jul;36(7):1269-81 - PubMed
  91. Cardiovasc Res. 1993 Apr;27(4):578-84 - PubMed
  92. J Clin Invest. 1990 Mar;85(3):731-8 - PubMed
  93. J Cardiovasc Pharmacol. 1994 Apr;23(4):647-52 - PubMed
  94. J Cell Biochem. 1995 Feb;57(2):321-30 - PubMed

Publication Types